- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
BTI forms magnetic-sensor joint venture
Biomagnetic Technologies of San Diego has formed a joint venture with another firm to develop high-temperature superconductive technology. In forming the joint venture, called Magnesensors, BTI will contribute its clean-room facility and superconducting
Biomagnetic Technologies of San Diego has formed a joint venture with another firm to develop high-temperature superconductive technology. In forming the joint venture, called Magnesensors, BTI will contribute its clean-room facility and superconducting device fabrication processes, while its partner, Quantum Magnetics of San Diego, will add its backlog of R&D contracts in the technology.
BTI and Quantum believe the technology to be developed by Magnesensors could be used for both healthcare and non-healthcare applications. For example, it could be used to monitor heart function of a fetus during pregnancy, or for industrial uses like detecting explosives. Magnesensors will be headed by former BTI veteran Mark Dilorio as president and CEO, and will start with equipment and personnel from both companies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
